Patent details

300872 Product Name: Combinatie van empagliflozine en linagliptine of een farmaceutisch aanvaardbaar zout daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300872
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2187879
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300872
Procedural language:
Dutch
First Applicant Residence Country:
Germany (DE)

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1146
Marketing Authorization Type:
EEA
Marketing Authorization Date:
15/11/2016
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
08/05/2017
First Marketing Authorization date:
15/11/2016
Grant date:
20/06/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
10/05/2017
SPC/SPC Extension Expiration Date:
14/11/2031
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
08/05/2017
 
 

 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216, INGELHEIM AM RHEIN, Germany (DE)

Agent

Name:
ir. F.A. Geurts c.s.
From:
08/05/2017
Address:
Octrooibureau Vriesendorp & Gaade B.V. Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
05/25
Publication date:
29/01/2025
Description:
Lapse or annulment

2

Bulletin Heading:
SPC
Journal edition number:
25/17
Publication date:
21/06/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
19/17
Publication date:
10/05/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/08/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
10/10/2025 Incoming Correspondence Electronic Accompanying letter incoming document 1 PDF /2/2/8/7/5/0800157822/docs/300872_9_incomingcorrespondenceelectronic20251010120109730.pdf
20/06/2017 SPC Documents Certificate SPC 1 PDF /2/2/8/7/5/0800157822/docs/300872_5_supplprotectioncertificate20170620112524700.pdf
20/06/2017 Outgoing Correspondence Decision grant 1 PDF /2/2/8/7/5/0800157822/docs/300872_8_outgoingcorrespondence20170620112524602.pdf
10/05/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /2/2/8/7/5/0800157822/docs/300872_3_136007l174.pdf
08/05/2017 Application Form First filed application form 3 PDF /2/2/8/7/5/0800157822/docs/300872_0_applicationform20170510012259899.pdf
08/05/2017 SPC Documents Annex SPC 2 PDF /2/2/8/7/5/0800157822/docs/300872_1_supplprotectioncertificate20170510012300276.pdf
08/05/2017 SPC Documents SPC Documents 26 PDF /2/2/8/7/5/0800157822/docs/300872_2_supplprotectioncertificate20170510012300217.pdf
08/05/2017 SPC Documents Marketing Authorization SPC 3 PDF /2/2/8/7/5/0800157822/docs/300872_4_supplprotectioncertificate20170510012300117.pdf
08/05/2017 SPC Documents Annex SPC 2 PDF /2/2/8/7/5/0800157822/docs/300872_6_supplprotectioncertificate20210113043048443.pdf
08/05/2017 SPC Documents Annex SPC 1 PDF /2/2/8/7/5/0800157822/docs/300872_7_supplprotectioncertificate20210113043518273.pdf